David Lloyd: Thanks Lisa Murphy for Your Leadership
David Lloyd, Chief Executive Officer at National Heart Foundation of Australia, reposted from Lisa Murphy and Stroke Foundation on LinkedIn:
”Great colleagues and friends in complete alignment on our mission – Heart Foundation and Stroke Foundation.
Thanks Lisa Murphy for your leadership in helping to bring our two organisations closer together than ever before, to better serve our overlapping patient communities.”
Quoting Lisa Murphy‘s post:
”Stronger Together”
Quoting Stroke Foundation‘s post:
”We are proud to announce the signing of a new collaborative agreement between Stroke Foundation and Heart Foundation.
The agreement commits both organisations to continue supporting the work of the National Hypertension Taskforce, including the development of updated clinical guidelines on lipid and blood pressure management, joint projects and evidence-based position statements.
High blood pressure (hypertension) is the leading risk factor for death in Australia, with around one in three Australians living with the condition.
With only 32% of Australians currently achieving adequate blood pressure control, collaborative sector approach comes at a crucial time to improve blood pressure control to 70% by 2030 in Australia.
Achieving better management of blood pressure and lipids will mean fewer heart attacks, fewer strokes, and healthier lives for Australians across the country.
This agreement demonstrates the ongoing commitment of Stroke Foundation and Heart Foundation to work together towards a common goal: better cardiovascular health for all Australians!
(photo caption: Stroke Foundation CEO Lisa Murphy and Heart Foundation CEO David Lloyd)”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids